Entera Bio Ltd. — Director's Dealing 2024

Apr 23, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2024-04-19

Reporting Person: Galitzer Hillel (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-04-19	Ordinary Shares, par value NIS 0.0000769 per share	A	30151	—	Acquired	64257	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-04-19	Stock Option (right to buy)	$1.99	A	130000	Acquired	2034-04-19	Ordinary Shares, par value NIS 0.0000769 per share (130000)	Direct

Footnotes

F1: Represent a grant of stock-settled restricted stock units. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 19, 2024.

F2: The options vest over a three-year period with 33% of the options vesting on April 19, 2025, the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining two-year period.